Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 304-990-8 | CAS number: 94313-91-4
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1999-04-13 to 1999-04-29
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Guideline study to GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 999
- Report date:
- 1999
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 472 (Genetic Toxicology: Escherichia coli, Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- 1992
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- Trimethyl-3-[(1-oxo-10-undecenyl)amino]propylammonium methyl sulphate
- EC Number:
- 304-990-8
- EC Name:
- Trimethyl-3-[(1-oxo-10-undecenyl)amino]propylammonium methyl sulphate
- Cas Number:
- 94313-91-4
- Molecular formula:
- C17H35N2O.CH3O4S
- IUPAC Name:
- bis(2-ethylhexyl) adipate
Constituent 1
Method
Species / strainopen allclose all
- Species / strain / cell type:
- E. coli WP2 uvr A pKM 101
- Additional strain / cell type characteristics:
- other: trptophan auxotroph
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- other: histidin auxotroph
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix (phenobarbital/ß-naphtoflavone induced), Lot-No. 070898, micorsomal protein-content: 24.7 mg/ml; purchased by CCR GmbH & Co. KG, 64380 Roßdorf, Germany
- Test concentrations with justification for top dose:
- Preliminary assay with TA 100 : 0.38, 0.76, 1.52, 3.03, 6.06, 12.13, 24.25, 48.5, 97.00 mg/plate
1st assay performed on all strains: 24.25, 76.69, 242.50, 766.85, 2425.00 µg/plate
2nd assay performed on all strains: 75.78, 151.56, 303.13, 606.25, 1212.5 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: Aqua dest.
Controlsopen allclose all
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene, 0.5 µg/plate for TA 100, TA 98, 2.0 µg/plate for TA 1535, TA 1537, and 1.0 µg/plate for E. coli with metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- methylmethanesulfonate
- Remarks:
- Migrated to IUCLID6: 12.9 µg/plate for E. coli without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- Migrated to IUCLID6: 50 µg/plate for TA 1537, without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-nitrofluorene, 0.2 µg/plate for TA 98 without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- Migrated to IUCLID6: 0.25 µg/plate for TA 100, TA 1535 without metabolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Exposure duration: 48 h
SELECTION AGENT (mutation assays): histidine for s.typhimurium strains, tryptophan for E. coli
NUMBER OF PLATES EVALUATED: 3 parallel plates were performed for each experimental point. Two indipendent experiments.
DETERMINATION OF CYTOTOXICITY
- Method: The highest concentration used in the test must either reduce the survival of the cells to at least 50 % or reduce the background growth of auxotrophic cells and the number of revertants.
OTHER: Because of the reduced background lawn in the 1st assay the 2nd assay was performed at a concentration range from 75.78 to 1212.5 1 µg/plate. - Evaluation criteria:
- Selection of the test compound:
The highest concentration used in the test must either reduce the survival of the cells to at least 50 % or reduce the background growth of auxotrophic cells and the number of revertants. If no toxicity is observed, the survey is carried out with the highest soluble concentration of the test article, however, not exceeding 5 mg/plate for solids and 10 mM of Iiquids or 200 µl/plate of liquids or extracts. The concentration intervals between the test doses have maximum a factor of sqrt. 10,
Analysis of results:
A test compound is considered as mutagenic if there is a dose dependent increase in the number of revertant colonies of one or more strains. For the highest non-toxic concentration an increase should be by a factor of about 2 and deemed to be biologically relevant. Any evidence af mutagenic activity must be reproducible in an independent experiment.
Results and discussion
Test resultsopen allclose all
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 1212.5 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Species / strain:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- 1212.5 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- PRELIMINARY TOXICITY TEST:
The test substance reduced the survival at a concentration of 1.52 mg/plate to 46.3 % of the control value. The number of the his-cells of the strain TA 100 at the concentration of 1.52 mg/plate was reduced to 58.3 % of the control value. No precipitation could be observed up to 97 mg/plate.
MAIN TEST:
The results of the 1st assay and the 2nd assay indicate, that in the tested concentration range (1 st assay: 24.25, 76.69, 242.5, 766.85 and 2425.0 µg/plate, 2nd assay: 75.78, 151.56, 303.13, 606.25 and 1212.5 µg/plate) with and without metabolic activation no significant increase in the numbers of his+- or trp+-revertants over the spontaneous values could be detected with the Salmonella strains TA 100, TA 1535, TA 98, TA 1537
and E. coli WP2 uvrA pKM(101).
Because of the reduced background lawn in the 1st assay the 2nd assay was performed at a concentration range from 75.78 to 1212.5 1 µg/plate.
STERILITY CONTROLS:
The plates for the sterility control of top agar, S9-mix and test compound showed no growth.
NEGATIVE CONTROLS:
In all experiments the control plates without mutagen showed a normal number of spontaneous revertants.
POSITIVE CONTROLS:
The positive controls demonstrated the sensitivity of the indicator strains and the activity of the metabolizing system. - Remarks on result:
- other: all strains/cell types tested
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with and without metabolic activation
Evaluation of the results of the two independent plate incorporation experiments did not provide evidence of a mutagenic potency of the substance.
Up to 2425.0 µg/plate, the substance did not induce biologically relevant increases in revertants in any of the tested strains. This applied to both the activated and the non-activated assay system. The substance is therefore found not to be genetically active under the aforementioned test conditions. - Executive summary:
In a reverse gene mutation assay in bacteria according OECD guidelines 471/472, and EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria), 1992, four strains of S. typhimurium (TA 1535, TA 1537, TA 100 and TA 98) and E. coli WP2 uvr A pKM 101 were exposed to the substance (48.5 % a.i. in Aqua dest.), at concentrations of 24.25, 76.69, 242.50, 766.85, 2425.00 µg/plate (1st assay) and 75.78, 151.56, 303.13, 606.25, 1212.5 µg/plate (2nd assay) in the presence and absence of mammalian metabolic activation (plate incorporation). Concentration selection for the first assay was based on a preliminary toxicity study with and without metabolic activation on strain TA 100 in which the concentration of 1.52 mg/plate was cytotoxic. Because of an reduced background lawn in the 1st assay the 2nd assay was performed at the concentration range from 75.78 to 1212.5 µg/plate.
No evidence of biologically significant mutagenic activity of the test item was found in the presence and absence of metabolic activation, up to and including the highest tested concentration of 2425 µg/plate. The test material was tested up to its toxic limit. The positive controls induced the appropriate responses in the corresponding strains and thus demonstrated the sensitivity of the indicator strains and the activity of metabolizing system..
There was no evidence of induced mutant colonies over background.
The adopted OECD TG 471 (1997) requires at least 5 test strains. These should include four strains of S. typhimurium (TA1535; TA137 or TA97a or TA97; TA98; and TA 100 and in addition the use of E. coliWP2 strains or Salmonella typhimurium TA 102 to detect certain oxidizing mutagens, cross-linking agents and hydrazines. This requirement is fulfilled by this test performed according to former versions of OECD guidelines 471/472 and EU Method B.13/14 (Version Commission Directive 92/69/EEC) on S. typhimurium (TA 1535, TA 1537, TA 100 and TA 98) and E. coliWP2 uvr A pKM 101.
Thus, this GLP test is considered as sufficient to evaluate the mutagenic activity of the substance in this bacterial test system.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
